BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14712779)

  • 1. [A case of undifferentiated bladder carcinoma with axilla lymph node metastasis successfully treated with gemcitabine and cisplatin].
    Takayanagi N; Chiba H; Sagawa T; Hirayama Y; Tsuji Y; Sakamaki S
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2137-40. PubMed ID: 14712779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
    Sternberg CN; Skoneczna I; Kerst JM; Albers P; Fossa SD; Agerbaek M; Dumez H; de Santis M; Théodore C; Leahy MG; Chester JD; Verbaeys A; Daugaard G; Wood L; Witjes JA; de Wit R; Geoffrois L; Sengelov L; Thalmann G; Charpentier D; Rolland F; Mignot L; Sundar S; Symonds P; Graham J; Joly F; Marreaud S; Collette L; Sylvester R; ; ; ; ;
    Lancet Oncol; 2015 Jan; 16(1):76-86. PubMed ID: 25498218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metastatic micropapillary variant of urothelial carcinoma of the urinary bladder responding to gemcitabine and cisplatin chemotherapy].
    Ishii T; Matsubara T; Taira H; Hiratsuka Y
    Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):540-4. PubMed ID: 23819368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of small cell carcinoma in the urinary bladder responding to gemcitabine/cisplatin combination therapy as neoadjuvant chemotherapy].
    Shirato A; Shimamoto K; Ozawa A; Tanji N; Yokoyama M
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2097-9. PubMed ID: 17197762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer.
    Iwasaki K; Obara W; Kato Y; Takata R; Tanji S; Fujioka T
    Jpn J Clin Oncol; 2013 Feb; 43(2):193-9. PubMed ID: 23275643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of metastatic bladder cancer].
    Gauthier H; Serrate C; Pouessel D; Le Maignan C; Teixeira L; Culine S
    Rev Prat; 2014 Dec; 64(10):1405-7. PubMed ID: 25668832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of regionally metastatic pure squamous cell carcinoma of the urinary bladder successfully treated with radical chemoradiotherapy].
    Inui M; Fujita K; Ueda N; Takenaka I; Kakehi Y
    Hinyokika Kiyo; 2002 Jan; 48(1):33-5. PubMed ID: 11868383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder.
    Birlik M; Akar S; Tuzel E; Onen F; Ozer E; Manisali M; Kirkali Z; Akkoc N
    J Cancer Res Clin Oncol; 2004 Feb; 130(2):122-5. PubMed ID: 14745551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [When should systemic chemotherapy be used for urinary bladder carcinoma?].
    Ohlmann CH; Stöckle M
    Urologe A; 2012 Mar; 51(3):325-30. PubMed ID: 22012589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of lymph-node dissection in patients undergoing radical cystectomy following previous oncological treatment for bladder cancer.
    Jensen JB; Ulhøi BP; Jensen KM
    Scand J Urol Nephrol; 2011 Dec; 45(6):436-43. PubMed ID: 21854099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel bladder preservation therapy BOAI-CDDP-radiation (OMC-regimen): a new treatment option for invasive bladder cancer patients with lymph node metastasis.
    Azuma H; Inamoto T; Takahara K; Nomi H; Hirano H; Ibuki N; Uehara H; Komura K; Minami K; Uchimoto T; Saito K; Takai T; Tanda N; Yamamoto K; Narumi Y; Kiyama S
    Int J Oncol; 2014 Jun; 44(6):1895-903. PubMed ID: 24728124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetramodal therapy using balloon-occluded arterial infusion of anticancer agents, the Azuma regimen, for lymph node-involved bladder cancer.
    Azuma H; Inamoto T; Takahara K; Ibuki N; Nomi H; Komura K; Uehara H; Minami K; Yamamoto K; Narumi Y
    Int J Oncol; 2019 Jan; 54(1):167-176. PubMed ID: 30387836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.
    Koie T; Ohyama C; Hashimoto Y; Hatakeyama S; Yamamoto H; Yoneyama T; Kamimura N
    Int J Clin Oncol; 2013 Aug; 18(4):724-30. PubMed ID: 23011100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy.
    Guzzo TJ; Resnick MJ; Canter DJ; Balandra A; Bergey MR; Magerfleisch L; Tomaszewski JE; Vaughn DJ; Malkowicz SB
    Can J Urol; 2010 Dec; 17(6):5465-71. PubMed ID: 21172112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy for muscle-invasive bladder cancer.
    Sun W; Vaughn DJ
    Semin Urol Oncol; 2001 Aug; 19(3):186-93. PubMed ID: 11561986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of diffusion-weighted MRI in monitoring response of lymph node metastatic bladder cancer treated with chemotherary].
    Nakayama T; Yoshida S; Fujii Y; Koga F; Saito K; Masuda H; Kobayashi T; Kawakami S; Kihara K
    Nihon Hinyokika Gakkai Zasshi; 2008 Nov; 99(7):737-41. PubMed ID: 19068691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A patient with recurrent gallbladder cancer responding to chemotherapy with CDDP/CPT-11 and gemcitabine].
    Yoneto T; Yoshikawa K; Fujii Y
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):99-102. PubMed ID: 15675592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy.
    Zargar H; Shah JB; van Rhijn BW; Daneshmand S; Bivalacqua TJ; Spiess PE; Black PC; Kassouf W;
    J Urol; 2018 Jun; 199(6):1452-1458. PubMed ID: 29329894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: focus on supplementary treatment strategies.
    Als AB; Sengelov L; von der Maase H
    Eur Urol; 2007 Aug; 52(2):478-86. PubMed ID: 17383078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy.
    Komai Y; Fujii Y; Okubo Y; Yamamoto S; Kawakami S; Yonese J; Fukui I
    Int J Urol; 2008 Oct; 15(11):971-5. PubMed ID: 18775029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.